Back

Eicosapentaenoic acid (EPA) inhibited lipoprotein(a) [Lp(a)] oxidation and its effects on expression of oxidative stress and pro-inflammatory proteins in endothelial cells

29 August 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Targeting lipoprotein-driven inflammation and oxidative stress in cardiovascular disease Lipids, Metabolism ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Preston Mason

Brigham and Women's Hospital and Brigham Health, Boston (United States of America)

7 More presentations in this session

Presentation thumbnail
Autoantibodies against apolipoprotein A-1 and cadmium: possible links to cardiovascular and liver diseases across multiple models
Doctor S. Pagano (Geneva, CH)
Abstract Slides Video
Presentation thumbnail
Electronegative H5 HDL: an apo(a)-containing HDL that damages neuronal DNA by potentially disrupting the BBB
Assistant Professor W. Hsu (Yunlin, TW)
Abstract Slides Video
Presentation thumbnail
The role and mechanism of METTL14/CCN3 axis in lipoprotein (a) [Lp(a)] induced human aortic smooth muscle cell calcification
Doctor Z. Li (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Nanoformulated omega-3 rich linseed oil reversed IL-6+TNF-a-induced M1 polarized THP-1 cells and monocytes of healthy donors and the activated monocytes of patients with coronary artery disease
Miss S. Hmadeh (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Atorvastatin active metabolite inhibits oxidation of Lp(a), small dense LDL and triglyceride-rich lipoproteins compared to other statins through a free radical scavenging mechanism
Doctor P. Mason (Boston, US)
Abstract Slides Video

Access the full session

Session thumbnail
Targeting lipoprotein-driven inflammation and oxidative stress in cardiovascular disease

The Event

Event poster

ESC Congress 2025

29 August 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
High glucose enhanced lipoprotein(a) [Lp(a)] oxidation in a manner inhibited by eicosapentaenoic acid (EPA) in vitro
thumbnail
Congress Presentation
Genetic variability of lipoprotein(a) controls vascular inflammation/redox signalling and predicts adverse cardiovascular outcomes in coronary artery disease
thumbnail
Congress Presentation
Lipoprotein(a) regulates vascular redox state and inflammatory response in patients with coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources